China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of calcium β-hydroxy-β-methylbutyrate (CaHMB) fortified oral nutritional supplementation on muscle condition and clinical outcomes after gastrointestinal tumor surgery'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131429
Registration Time: 2026/09/02
Type: Interventional study
Primary Sponsor: Shanghai Sixth people's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=321693
Published by HT Digital Content Services with permission from Health Daily Digest....